“approval” Archives

in
Entry Author Date Location
Biohaven’s Acute Migraine Drug Bests Placebo in Prevention Study 03/30/20 National
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It? 10/10/19 National
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More 08/31/18 National
FDA Gives Thumbs-Down to Rare Disease Drug from Ionis, Akcea 08/27/18 San Diego
Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More 08/17/18 National
Bio Roundup: Alnylam’s Moment, Read on Rebates, Skinny Plans & More 08/03/18 National
EU Regulators Approve Akcea’s Inotersen. FDA Decisions Are Next. 07/11/18 Boston
Bio Roundup: Dunsire’s Danish, Price Hikes, Rare-Disease Race & More 07/06/18 National
With New Data, Karyopharm Says It Will Ask for Myeloma Approval 04/30/18 Boston
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Bio Roundup: Trump Health, Cholesterol Wars, 23andMe OK & More 03/09/18 National
Bio Roundup: Trump’s Budget, Biogen’s AD Reveal, Hugin’s Run & More 02/16/18 National
Bristol-Myers Bets Nearly $2B on Nektar for an Immunotherapy Boost 02/14/18 New York
Bio Roundup: Tax Cuts, a Funding Rush, Hemophilia Questions & More 12/15/17 National
Bio Roundup: ICER Eyes Cost, Azar at HHS, Gates’s ALZ Cash & More 11/17/17 National
FDA To Advisors: What If One-Time Gene Therapy Needs Extra Doses? 10/10/17 National
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More 08/11/17 National
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer 07/24/17 Boston
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Unanimous Advice To FDA: Approve Landmark CAR-T Cancer Therapy 07/12/17 National
Before Key Meeting, FDA Stresses Risks of Novartis CAR-T Cancer Therapy 07/10/17 National
Page 1 of 2 next page »